1.
About the Evidence of Tumor Marker in Tumor Studies
肿瘤与肿瘤标志物研究中证据的思考
2.
Diagnostic significance of CA19-9 in digestive system cancer
肿瘤标志物CA19-9在消化道肿瘤诊断中的应用
3.
Cap43 as a Tumor Marker in Nickel Induced Lung Cancer;
Cap43作为镍接触肺癌肿瘤标志物的研究
4.
Screening and Functional Studies of Novel Tumor Markers
新肿瘤标志物的筛选及功能初步研究
5.
An Update of Biomarkers in Prostate Cancer Tissue
前列腺癌组织学肿瘤标志物研究进展
6.
Detection of serum protein biomarkers by surface enhancedlaser desorption ionization time of flight mass spectrometry(SELDI-TOF-MS) in patients with non-small cell lung cancer
SELDI-TOF-MS技术筛选NSCLC血清肿瘤标志物
7.
Clinical Value of Combined Detection of Tumor Markers for Lung Cancer
肿瘤标志物联合检测肺癌的临床价值
8.
The Application of Tumor Markers in Clinical Diagnosis
肿瘤标志物在临床诊断中的应用述评
9.
The Application Research of Tumor Marker in the Diagnose of Archenteric Cancer
消化系统癌诊治中肿瘤标志物的应用
10.
Significance of Ten Tumor Markers in Diagnosis of Liver Cancer
10种肿瘤标志物对肝癌诊断的评价
11.
Study on the Anti Mullerian Hormone Served as a Marker for Granulosa Cell Tumorof Ovary
抗苗勒管激素作为卵巢颗粒细胞瘤肿瘤标记物的实验研究
12.
Tumor type M2 pyruvate kinase-the new tumor marker in colorectal cancer
结直肠恶性肿瘤的新标志物—肿瘤型丙酮酸激酶
13.
Oncoproteomics and alimentary system tumor biomarkers
肿瘤蛋白质组学与消化系肿瘤生物标记
14.
Feasibility of Oncolytic Adenovirus Labeled With Radionuclides for Treating Tumors
放射性核素标记溶瘤腺病毒治疗肿瘤的可行性
15.
an antineoplastic antibiotic drug (trade name Mithracin) used to treat cancer of the testes.
用来治疗癌症的抗肿瘤药物（商标是Mithracin）。
16.
an antineoplastic drug (trade name Velban) that disrupts cell division.
破坏细胞分解的抗肿瘤药物（商标是Velban）。
17.
Now the remedial target of be particular about is person tumour coexists for a long time.
现在讲求的治疗目标是人瘤长期共存。
18.
Now an independent prognostic molecular marker has not been identified as yet.
尚未发现特异的肿瘤诊断分子标记物。